“…While data on treatments and health outcomes for persons with T2DM in the Arabian Gulf States are becoming available [ 9 – 12 ], there is still a scarcity of assessments of the quality of care received. The need for robust data to monitor T2DM management in the UAE was recently highlighted in the Lancet [ 13 ]; the authors emphasized the challenges facing primary care physicians to improve provision of healthcare, without reliable baseline and comparative data [ 13 ]. As it stands, the extent to which the contemporary management of T2DM patients in Dubai meets recommended guidelines is not known.…”
Objective. As little data are available on the quality of type 2 diabetes mellitus (T2DM) care in the Arabian Gulf States, we estimated the proportion of patients receiving recommended monitoring at the Dubai Hospital for T2DM over one year. Methods. Charts from 150 adults with T2DM were systematically sampled and quality of care was assessed during one calendar year, using a Healthcare Effectiveness Data and Information Set- (HEDIS-) like assessment. Screening for glycosylated haemoglobin (HbA1c), low-density lipoprotein (LDL), blood pressure, retinopathy, and nephropathy was considered. Patients were classified based on their most recent test in the period, and predictors of receiving quality care were examined. Results. Mean age was 58 years (standard deviation (SD): 12.4 years) and 33% were males. Over the year, 98% underwent HbA1c screening (50% had control and 28% displayed poor control); 91% underwent LDL screening (65% had control); 55% had blood pressure control; 30% had retinopathy screening; and 22% received attention for nephropathy. No individual characteristics examined predicted receiving quality care. Conclusion. Some guideline monitoring was conducted for most patients; and rates of monitoring for selected measures were comparable to benchmarks from the United States. Greater understanding of factors leading to high adherence would be useful for other areas of preventive care and other jurisdictions.
“…While data on treatments and health outcomes for persons with T2DM in the Arabian Gulf States are becoming available [ 9 – 12 ], there is still a scarcity of assessments of the quality of care received. The need for robust data to monitor T2DM management in the UAE was recently highlighted in the Lancet [ 13 ]; the authors emphasized the challenges facing primary care physicians to improve provision of healthcare, without reliable baseline and comparative data [ 13 ]. As it stands, the extent to which the contemporary management of T2DM patients in Dubai meets recommended guidelines is not known.…”
Objective. As little data are available on the quality of type 2 diabetes mellitus (T2DM) care in the Arabian Gulf States, we estimated the proportion of patients receiving recommended monitoring at the Dubai Hospital for T2DM over one year. Methods. Charts from 150 adults with T2DM were systematically sampled and quality of care was assessed during one calendar year, using a Healthcare Effectiveness Data and Information Set- (HEDIS-) like assessment. Screening for glycosylated haemoglobin (HbA1c), low-density lipoprotein (LDL), blood pressure, retinopathy, and nephropathy was considered. Patients were classified based on their most recent test in the period, and predictors of receiving quality care were examined. Results. Mean age was 58 years (standard deviation (SD): 12.4 years) and 33% were males. Over the year, 98% underwent HbA1c screening (50% had control and 28% displayed poor control); 91% underwent LDL screening (65% had control); 55% had blood pressure control; 30% had retinopathy screening; and 22% received attention for nephropathy. No individual characteristics examined predicted receiving quality care. Conclusion. Some guideline monitoring was conducted for most patients; and rates of monitoring for selected measures were comparable to benchmarks from the United States. Greater understanding of factors leading to high adherence would be useful for other areas of preventive care and other jurisdictions.
“…High rates of childhood obesity, diabetes, renal failure, and other chronic conditions are of key concern within the UAE. While it is difficult to access valid and contemporaneous data (S. Brownie et al., 2014 ; Hunter, Robb, & Brownie, 2014 ) that permits the comparison of the health of the UAE population against the health of other countries, in 2014, the comparative prevalence rate of diabetes (among the adult population) in UAE (at 19.02%) was more than double the global comparative prevalence ( International Diabetes Federation, 2014 ). Obesity and overweight amongst children and adolescents, increasing the risk of metabolic and chronic diseases, has also attracted much attention in the UAE ( Al Junaibi, Abdulle, Sabri, Hag-Ali, & Nagelkerke, 2013 ; Al-Haddad, Little, & Abdul-Fhartoor, 2005 ; Al-Sharbatti et al., 2011 ; Hajat, Harrison, & Shather, 2012 ; Katsaiti & El Anshasy, 2013 ).…”
Section: Emerging Roles For Nurses In the Uaementioning
confidence: 99%
“…Introduction of nursing-related legislation and endorsement of standards, as outlined in Table 3 , will complete the regulatory foundations needed to establish advanced and speciality practice roles. Once uniform laws are implemented, opportunities for the registration and licensing of advanced and speciality nursing and midwifery roles in the UAE will be facilitated, and the mechanism by which nurses and midwives could make significant contributions to the prevention and management of preventable noncommunicable and chronic disease and the development of public health services across the UAE will be established (S. Brownie, Lebago, & Hag-Ali, 2014 ).…”
Section: Current Policy and Statutory Considerations Specific To The mentioning
In 2009, the United Arab Emirates (UAE) established a Nursing and Midwifery Council with a mandate to develop standards for the registration and regulation of nursing and midwifery and to strengthen the nursing and midwifery workforce. Priorities included workforce Emiratization and the development of regulatory standards to support advanced and speciality nursing practice and new models of care—particularly for the management of noncommunicable diseases. This article provides background, context for, and best practice inputs to the effort to provide one unified framework of nursing regulation and licensure across the whole of the UAE. This article is intended for nurse leaders, policy makers, and regulators who are reviewing or developing nursing regulatory processes and advancing nursing workforce capacity building activities; and nurse educators and nurses wishing to work in the UAE.
“…It has been found that population in the United Arab Emirates (UAE) are highly susceptible to DM and its complications. In 2013, the age-standardized comparative prevalence of DM in UAE was 18.98%, amongst the highest in the world whereas the global comparative prevalence was 8.3% [ 12 ]. IDF has revealed that, in 2017, 17.3% of the UAE population between the ages of 20 and 79 have, in particular, Type 2 DM (T2DM) [ 13 ].…”
Background:
Diabetes mellitus (DM) is one of the most prevalent metabolic diseases in
the UAE. During the last two decades, the United Arab Emirates (UAE) has experienced tremendous
development in all fields including DM research. The present study sheds light on the growth in DM
research in UAE and represents a guide for DM researchers to create more focused future directions
in DM research.
Objective:
The main objective of the present study is to investigate and document the changes that
occurred in DM research in the UAE over the last two decades.
Methods:
Several research databases were reviewed and all the articles that involved any form of DM
research within the UAE were selected. Inclusion criteria were: (i) Research studies related to DM
and conducted by institutions based in UAE (ii) Research studies related to DM and conducted in the
population of UAE and (iii) Research articles related to DM and the authors (principal investigators or
co-investigators) are from UAE.
Results:
Between the years of 1996 and 2000, there was an average of 6.4 articles about DM being
published per year. This pattern changed dramatically between years 2011 to 2015 where an average
of 22.8 articles were being published. In addition, a significant increase was noticed in the year 2015
with 42 articles published per year. It was also found that 46.8% articles involved clinical study,
12.1% were basic research, 17.5% cross-sectional studies, 8.91% reviews, 8.2% were cohort and all
the other types of research represented about 5.58%.
Conclusion:
Significant progress has been noticed in DM research in the UAE during the last two
decades. Based on the findings of the present study, more focus should be given to the case reports
and clinical trials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.